Skip to main content
. 2019 Sep 6;19:646. doi: 10.1186/s12913-019-4493-3

Table 2.

Appropriateness of eye care by domain of care. Numbers are percentage of encounters with appropriate care (number of quality indicators). If more than one quality indicator was assessed, the percentage of encounters with appropriate care is presented as a range of percentage. NZ = New Zealand, A&E = accident and emergency, N/A = not applicable as no specific timing was measured

Country Year Health Practitioner Timing Domain of care Author (reference)
History taking Physical examination Management Recall period Referral Patient education
Glaucoma
 UK 2013 Ophthalmologist All visits (at least up to 17.5 years) 0,87% (1)a Fung et al. [26]
 UK 2012 Optometrist First visit 74–100% (6) 96% (1) Chawla et al. [27]
First follow-up visit 88% (1) 94–100% (3) 92% (2)
Ophthalmologist First visit 10–100% (6) 100% (1)
First follow-up visit 24% (1) 8–100% (3) 66–86% (2)
 UK 2012 Optometrist Referral letter for glaucoma diagnosis

70% (1)b

4–99% (6)c

Khan et al. [29]
 UK 2012 Optometrist Results of interview 77% (1) 19–98% (4) Theodossiades et al. [31]
First visit of standardised patient 41% (1) 3–100% (4)
 UK 2011 Ophthalmologist N/A 23% (1) Stead et al. [32]
 UK 2009 Optometrist Referral letter for glaucoma diagnosis 27–100% (14)c Scully et al. [35]
 UK 2012 Optometrist First full visit 91–98% (1) 97% (1) 87% (1)2 Marks et al. [36]
 UK 2011 Optometrist All follow-up visits 96% (1) 99% (1) 93% (1) Ho and Vernon [37]
 UK 2011 Optometrist Referral letter for glaucoma diagnosis 25% (1)b Shah and Murdoch [38]
 UK 2010 Optometrist All visits 93% (1) 86% (1) Syam et al. [39]
 UK 2010 Optometrist Referral letter for glaucoma diagnosis

37% (1)b

72–99% (3)c

Lockwood et al. [40]
 UK 2007 Optometrist First visit 85% (1) Azuara-Blanco et al. [41]
Ophthalmologist First visit 83% (1)
 UK 2006 Optometrist Referral letter for glaucoma diagnosis 45% (1)b Patel et al. [42]
 UK 2006 Optometrist All follow-up visit 62–98% (5) 72–97% (5) 79% (1) Banes et al. [43]
Associate specialists All follow-up visit 54–100% (5) 71–99% (5) 73% (1)
 USA 2016 Ophthalmologist All follow-up visits 68% (1) Solano-Moncada et al. [45]
 USA 2016 Ophthalmologist & optometrist All visits within 2 years after glaucoma diagnosis 27–74% (2) Elam et al. [46]
 USA 2015 Resident ophthalmologist Third (or more) follow-up visit 88% (1) 62–100% (5) 74% (1) Zebardast et al. [48]
Faculty ophthalmologist Third (or more) follow-up visit 100% (1) 87–100% (5) 100% (1)
 USA 2013 Resident ophthalmologist First follow-up visit 49–97% (5) 93–100% (4) 82–100% (6) 96–97% (2) 16% (1) 5% (1) Ong et al. [50]
 USA 2012 Ophthalmologist & optometrist All visits within 3 years after glaucoma or glaucoma suspect diagnosis 12–34% (2) Swamy et al. [51]
 USA 2007 Ophthalmologist First claim for a prostaglandin prescription 50–90% (5) 19% (1) 100% (1) 38% (1) Quigley et al. [52]
 USA 2006 Ophthalmologist All visits within 5 years before surgery for glaucoma 49% (1) Coleman et al. [54]
 Australia & NZ 2015 Optometrist (Australia) N/A 99% (1) 25–100% (10) Zangerl et al. [56]
Optometrist (NZ) N/A 100% (1) 27–100% (10)
 Australia & NZ 2008 Ophthalmologist N/A 13–96% (4) Liu [59]
 Scotland 2015 Optometrist Referral letter for glaucoma diagnosis BEFORE guidelines published

62% (1)b

33–85% (3)c

El-Assal et al. [61]
Referral letter for glaucoma diagnosis AFTER guidelines published

76% (1)b

76–81% (3)c

 Scotland 2009 Optometrist Referral letter for glaucoma progression BEFORE guidelines published

18% (1)b

2–94% (7)c

Ang et al. [62]
Referral letter for glaucoma progression AFTER guidelines published

32% (1)b

24–93% (7)c

 Canada 2014 Ophthalmologist Referral letter for glaucoma diagnosis 10–100% (16)c Cheng et al. [64]
Optometrist Referral letter for glaucoma diagnosis 7–100% (16)c
 Germany 2008 Ophthalmologist N/A 96% (1) Vorwerk et al. [65]
 Singapore 2008 Ophthalmologist N/A 75–93% (2) Ang et al. [67]
Diabetic retinopathy
 Australia 2011 Optometrist N/A 83–99% (2)b Slater and Chakman [69]
 Australia 2011 Optometrist N/A 43–96% (6) 23–89% (2) 6–98% (12)d Ting et al. [71]
 Australia 2010 Ophthalmologist N/A 41–55% (4) 49–90% (2) 56–94% (2) 38–71% (10)d Yuen et al. [72]
 NZ 2012 Optometrist Fundus screening visit 60% (1)b Hutchins et al. [74]
 USA 2012 Ophthalmologist & optometrist N/A 71% (1) Chou et al. [76]
 USA 2010 Resident ophthalmologist First ever diabetic retinopathy examination 41–57% (5) 0–100% (7) 70–79% (2) 69–70% (2) 0–27% (3) Tseng et al. [78]
 Hong Kong 2016 General practitioner N/A 33% (1) 27% (1) Wong et al. [80]
 Bahrain 2014 General practitioner at general practitioner clinic All follow-up visits within previous 12 months 0% (1)e Al-Ubaidi et al. [82]
General practitioner at diabetes care clinic All follow-up visits within previous 12 months 87% (1)e
 Switzerland 2013 General practitioner First hospitalisation 31% (1)e Burgmann et al. [84]
 UK 2011 General practitioner Second diabetic visit 71% (1)e Mc Hugh et al. [86]
 Brazil 2007 General practitioner N/A 34–87% (2)e Preti et al. [88]
Age-related Macular Degeneration
 Italy 2016 Ophthalmologist N/A 44% (1) Parodi et al. [93]
 Turkey 2015 Ophthalmologist N/A 23% (1) Muhammed et al. [95]
 UK 2013 Ophthalmologist & optometrist N/A 21–32% (2) 28–70% (5) 49% (1) Lawrenson and Evans [100]
 USA 2008 Ophthalmologist N/A 76% (1) Charkoudian et al. [103]
Cataract
 UK 2011 Ophthalmologist N/A 51–99% (3) Gomaa and Liu [105]
 UK 2009 Optometrist Referral letter for cataract surgery 0–100% (10)c Park et al. [107]
General practitioner Referral letter for cataract surgery 0–100% (10)c
 UK 2006 Optometrist Referral letter for cataract surgery 48% (1)c Lash et al. [109]
 USA 2009 Resident ophthalmologist Preoperative care visits for first cataract surgery 73–100% (4) 59–100% (9) 0–100% (9) Niemiec et al. [111]
All postoperative follow-up visits for first cataract surgery 14–78% (6) 77–100% (7) 98% (1) 98% (1) 43% (1)b 98% (1)
Preventative eye care
 UK 2009 Optometrist First visit 95% (1) 0–100% (5) Shah et al. [115]
 UK 2009 Optometrist First visit 26–87% (8) 24–99% (10) 29% (1) Shah et al. [118]
 UK 2008 Optometrist First visit 1–100% (14) 59–100% (8) 14–80% (6) Shah et al. [120]
 Australia 2015 Optometrist N/A 47–55% (2) 62–80% (2) Downie and Keller [129]
Dry eye
 Australia 2013 Optometrist N/A 4–93% (3) Downie et al. [132]
 USA 2010 Ophthalmologist Initial diagnosis visit BEFORE guidelines revised 6–99% (12) 6–100% (12) 5–90% (5) 48% (1)b 47–89% (3) Lin et al. [134]
Initial diagnosis visit AFTER guidelines revised 6–100% (16) 6–100% (13) 0–100% (7) 33% (1)b 33–89% (4)
All ocular conditions at A&E
 UK 2007 Optometrist First visit 91% (1) Hau et al. [135]
Amblyopia
 USA 2013 Ophthalmologist Initial visit 12–24% (2) Jin et al. [138]
Esotropia
 USA 2010 Ophthalmologist Initial esotropia evaluation 64% (4)f 99.6% (6)f 94% (4)f 94% (2)f Gupta et al. [140]
70% (4)g 90% (6)g 94% (4)g 94% (4)g
Non-infectious uveitis
 USA 2011 Ophthalmologist & rheumatologist All visits since initial diagnosis 12–23% (2) Nguyen et al. [142]

aFung et al. [26] reported 0 and 87% compliance for frequency of visual fields examination against two sets of glaucoma guidelines, the European Glaucoma Society (EGS) [24] and the United Kingdom’s National Institute for Health and Clinical Excellence (NICE) guidelines [25], respectively. bPercentage of appropriateness of referral to relevant health practitioners. cPercentage of appropriate content of the referral letters. d‘’Recall period’ and ‘referral’ were assessed by the same set of case vignettes [71, 72]. ePercentage of diabetic patients who visited general practitioners and were arranged a diabetic retinopathy screening by ophthalmologists. fMean appropriate care measured against guidelines published by American Academy of Ophthalmology (AAO) in 2002. Appropriate care was defined as documentation of 50% or more of the specific parameters listed for each quality indicator. gMean appropriate care measured against guidelines published by NICE in 2007. Appropriate care was defined as documentation of 50% or more of the specific parameters listed for each quality indicator

HHS Vulnerability Disclosure